Get started
Author

Dipti Tankala

Observed names: D Tankala, D. Tankala, Tankala, Dipti
ORCID: 0009-0008-4849-2442
Observed ORCID: 0009-0008-4849-2442
OpenAlex ID: A5032960170
Early access for innovative oncology medicines: a different story in each nation
2023 · Tara Cowling, Ransi Nayakarathna, et al. · Journal of Medical Economics · 27
PDF
An Observational Case Study of Near-peer Teaching in Medical and Pharmacy Experiential Training
2016 · Bayan Sharif-Chan, Dipti Tankala, et al. · American Journal of Pharmaceutical Education · 14
PDF
Understanding real‐world treatment patterns and clinical outcomes in AL amyloidosis patients diagnosed in Canada: A population‐based cohort study
2022 · Victor H. Jimenez‐Zepeda, Donna Reece, et al. · eJHaem · 8
The Economic Impact of Treatment Sequencing in Chronic Lymphocytic Leukemia in Canada Using Venetoclax plus Obinutuzumab
2024 · Kimberly Guinan, Karine Mathurin, et al. · Cancers · 1
PDF
P-019: Real-world treatment patterns, clinical outcomes, and healthcare resource utilization of individuals with light chain (AL) amyloidosis in Alberta, Canada: a population-based study
2021 · Victor H Jimenez-Zepeda, Donna E. Reece, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
Peer Teaching: A Qualitative Comparison between Medical and Pharmacy Trainees
2014 · M. Battistella, D. Tankala, et al. · Research in Social and Administrative Pharmacy · 1
Health care resource use in the management of patients with relapsed/refractory diffuse large B-cell lymphoma – Canadian perspective
2026 · Kimberly Guinan, Mathieu Pelletier, et al. · Journal of Comparative Effectiveness Research
Supplementary data: Health care resource use in the management of patients with relapsed/refractory diffuse large B-cell lymphoma – Canadian perspective
2026 · Guinan, Kimberly, Pelletier, Mathieu, et al. · Figshare
A Canadian Cost-Utility Analysis of Epcoritamab Versus Current Therapies in Third-Line or Later Large B-Cell Lymphoma
2024 · Shivani Kamdar, David Macdonald, et al. · Blood
EE473 Health Care Resource Use in the Management of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Canada
2024 · K Guinan, M Pelletier, et al. · Value in Health
PDF
Validation of an administrative coding algorithm for the identification of individuals with amyloid light chain amyloidosis using administrative data
2022 · Victor H. Jimenez-Zepeda, Donna Reece, et al. · Leukemia & lymphoma/Leukemia and lymphoma
The Economic Impact of Treatment Sequencing in the Management of Chronic Lymphocytic Leukemia in Canada Using Venetoclax Plus Obinutuzumab
2022 · Kimberly Guinan, Jean Lachaine, et al. · Blood
Works count: 12
Citation count: 52
H-index: 3
I10-index: 2
Year
Topic
Type